Canadian CLL Researcher awarded grant

[Guest guest]

Dr. Spencer Gibson, M.D. of the University of Manitoba has

received a grant from the CLL Global Research Foundation.

Dr. Gibson's research involves the tyrosine kinase inhibitor

gefitinib, currently used in treating lung cancer.

His research will assess whether the drug gefitinib can

selectively kill ZAP-70 expressing CLL cells by inhibiting

ZAP-70 function.

The grant of $100,000 is for one year of research funding

with the possibility of a second year.

http://www.cllglobal.org/research/individual.htm

~chris

CLL CANADA